← Atlas Theme · spans 1 topics
Federal manufacturing fast-tracks shield critical clinical supply chains from geopolitical reliance.
Faced with geopolitical competition and severe supply vulnerabilities, federal agencies are launching pre-clearance pilot programs that move facility and compliance verification to the early stages of drug development.
1
Topics it spans
2
Findings citing it
—
Evidence window
The convergence
The same conclusion keeps arriving from across the workspace's research — 1 topics independently instantiate this theme. Filter the evidence by where it came from:
Science & Health
HHS and FDA's "Operation Trialblazer": Accelerating Clinical Trials — Now with ARPA-H's SURPASS, STACK, COMMONS, and CINCH This pilot program establishes a pre-clearance research network specifically to prevent early-stage clinical pipelines from migrating to geopolitical rivals.
Science & Health
FDA Launches Inaugural PreCheck Pilot Program to Accelerate Domestic Drug Manufacturing The launch of the PreCheck pilot program allows developers to clear domestic facility compliance issues early in the drug development lifecycle.